S&P DJI Announces March 2019 Quarterly Rebalance
Filed with ASX · · 6 pages · English
Earlier from Somnomed
- Core revenue growth up 13% in Q2
- 2018 AGM addresses - Chairman and CEO
- Change in Leadership of SomnoMed
- Response to Appendix 4C Query
- Strong first quarter in Core business diluted by RSS results
Later from Somnomed
- Core revenue growth up 9% in Q3
- 500,000 patients treated worldwide
- North American direct revenues up 31% in Q4
- Strong North American revenue growth in Q1
- Core revenue growth up 19% in Q2
Follow Somnomed into a list and get an email when it puts out news.
Follow Somnomed